(Q82320635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Marija Pastorcic-Grgic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Bozena Sarcevic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Danijel Dosen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Antonio Juretic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Giulio C Spagnoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Marko Grgic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1178-1184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.

15 January 2020

cites work

1 reference

7 January 2021

Novel markers for poor prognosis in head and neck cancer.

1 reference

7 January 2021

Molecular pathogenesis of head and neck squamous cell carcinoma

1 reference

7 January 2021

Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal

1 reference

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

7 January 2021

Cancer immunotherapy in clinical oncology

1 reference

7 January 2021

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

1 reference

7 January 2021

Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy

1 reference

7 January 2021

A listing of human tumor antigens recognized by T cells

1 reference

7 January 2021

Expression of MAGE-antigens in normal tissues and cancer

1 reference

7 January 2021

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

1 reference

7 January 2021

T-cell recognition of melanoma-associated antigens

1 reference

7 January 2021

Expression of MAGE genes in primary and metastatic cutaneous melanoma

1 reference

7 January 2021

Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies

1 reference

7 January 2021

Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study.

1 reference

7 January 2021

Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study

1 reference

7 January 2021

Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma

1 reference

7 January 2021

Expression of the MAGE gene family in human head‐and‐neck squamous‐cell carcinomas

1 reference

7 January 2021

Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma

1 reference

7 January 2021

Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4

1 reference

7 January 2021

NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study

1 reference

7 January 2021

NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

1 reference

7 January 2021

Potential molecular prognostic markers in head and neck squamous cell carcinomas

1 reference

7 January 2021

About human tumor antigens to be used in immunotherapy

1 reference

7 January 2021

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma

1 reference

7 January 2021

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

1 reference

7 January 2021

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

7 January 2021

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

1 reference

7 January 2021

NY-ESO-1 expression and immunogenicity in esophageal cancer.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20029985%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference